Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • aprice67
    Member
    • Nov 2012
    • 49

    #1

    Cuffset number of genes too high

    Hi,

    So I'm implementing a pretty standard tuxedo pipeline on paired-end mouse data. I went along as follows.

    Using the standard mouse build (37) from Ensemble and the associated annotation data I did the following.

    cutadapt -> tophat2 -> cufflinks -> cuffmerge -> cuffquant -> cuffdiff -> cummerbund.

    Tophat2 is giving me roughly 85% overall mapping, 5-10% multimap. Cufflinks was run on around 100 files and those were merged with cuffmerge. All of the bam files were then run with cuffquant using the gtf from cuffmerge.

    To test out an initial dataset I just used two sample conditions (2 replicates each) to do cuffdiff. 8 files. (4 control, 4 corresponding experimental case).


    Now, I load this up in cummeRbund and see the following:
    CuffSet instance with:
    2 samples
    52615 genes
    220501 isoforms
    106928 TSS
    49476 CDS
    52615 promoters
    106928 splicing
    21223 relCDS
    So this is my first time working with mouse or cufflinks pipeline, but somehow these numbers don't feel right. So I checked it out and at least I found that mouse has only around 23,000 genes, so thats wrong for sure.

    Could someone explain to me what sort of numbers I should be seeing here and why at least cuffdiff/cummRbund is showing approximately double the number of genes that should exist in the genome I'm looking at?

    I appreciate any feedback anyone can provide.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 02:55 AM
0 responses
5 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Working...